INST Committee Meeting
Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.
For an advanced search, use Publication Search tool.
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
MINUTES OF PROCEEDINGS
Meeting No. 49
Monday, June 2, 2003
The Standing Committee on Industry, Science and Technology met in a televised session at 3:30 p.m. this day, in Room 253-D, Centre Block, the Chair, Walt Lastewka, presiding.
Members of the Committee present: André Bachand, Larry Bagnell, Paul Crête, Brian Fitzpatrick, Walt Lastewka, Serge Marcil, Brian Masse, Dan McTeague, Hon. Gilbert Normand, James Rajotte, Andy Savoy, Brent St. Denis and Joseph Volpe.
Acting Members present: Rob Merrifield for Cheryl Gallant and Marlene Jennings for Paddy Torsney.
In attendance: From the Library of Parliament: Geoffrey P. Kieley and Dan Shaw, Research Officers.
Witnesses: From the Department of Industry: Andreï Sulzenko, Senior Assistant Deputy Minister, Policy Sector; Marie-Josée Thivierge, Director General, Marketplace Framework Policy Branch; Eric Dagenais, Acting Director, Patent Policy Directorate; Douglas Clark, Acting Senior Project Leader, Patent Policy Directorate; Rob Sutherland-Brown, Senior Counsel, Legal Services. From the Department of Health: Dr. Robert Peterson, Director General, Therapeutics Products Directorate, Health Products and Food Branch; David Lee, Director, Office of Patented Medicines and Liaison; Anne Bowes, Manager, Patent and Liaison; David K. Edwards, Legal Counsel, Legal Services.
Pursuant to Standing Order 108(2), the Committee proceeded to the consideration of the Automatic Injunction Provisions in the Patented Medicine (Notice of Compliance) Regulations of the Patent Act.
Andreï Sulzenko made an opening statement and, with Eric Dagenais, Douglas Clark and Marie-Josée Thivierge answered questions.
Robert Peterson made an opening statement and, with David Lee answered questions.
At 5:32 p.m., the Committee adjourned to the call of the Chair.
Jean-François Pagé
Clerk of the Committee